Life Sciences Times

AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer

Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab

Akroswiss takes a step forward in the interest of patients closing a multi-million CHF Seed-Series Funding Round

Deerfield Management and Baylor College of Medicine Announce Blue Square Discoveries to Advance Novel Therapeutic Treatments

Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Tumor Potential of Proenzymes

Aceto Expands Life Science Manufacturing with Acquisition of Finar Limited

Nationwide Survey by Averitas Reveals Painful Realities of Living with Diabetic Nerve Pain

India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Kelso & Company Acquires Silver Spur; Combines with Existing Investments in C.L. Smith and Inmark

Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Deuterated Psilocybin Products